Celiac Disease Treatment Market By Treatment Type (Drug Class {Immunosuppressants, Enzyme Replacement Therapy, Corticosteroids, Biologics, Others} Therapeutic Treatments, Dietary Management, Surgical Interventions), By Mode of Administration (Oral, Injectables, Topical), By End-User (Hospitals, Clinics, Home Care Settings), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Dec 2024 | Report ID: MI1527 | 220 Pages

Report Summary Table of Contents Segmentation FAQ Request Sample Report

Report Coverage:

By Treatment Type

  • Drug Class
    • Immunosuppressants
    • Enzyme Replacement Therapy
    • Corticosteroids
    • Biologics
    • Others
  • Therapeutic Treatments
  • Dietary Management
  • Surgical Interventions

By Mode of Administration

  • Oral
  • Injectables
  • Topical

By End-User

  • Hospitals
  • Clinics
  • Home Care Settings

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Innovate Biopharmaceuticals, Inc.
  • ImmunogenX
  • ImmusanT Inc.
  • Alvine Pharmaceuticals, Inc.
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd.
  • AbbVie Inc.
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Biomedal S.L.
  • Dr. Schär AG
  • Celimmune LLC
  • Calypso Biotech BV
  • ActoBio Therapeutics

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing